La vendita allo scoperto per Waystar Holding dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Waystar Holding. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Waystar Holding (NASDAQ:WAY) Azioni, Report sulle vendite allo scoperto

Waystar Holding

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in better transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for our solutions extends throughout the United States and includes Puerto Rico and other US Territories.

Waystar Holding Corp

Wayne Savings Bancshares Inc Com

Wave Sync Corp

WAYFAIR CL A ORD

Wayfair Inc

WaykiChain

WAYLAND GROUP CORP ORD by Wayland Group Corp.

Wayland Group Corp

WAYPOINT BIOMED HLDGS INC by WayPoint Biomedical Holdings, Inc.

Waypoint Biomedical Holdings Inc

Waypoint REIT Ltd

Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.17) by 23.53 percent. The company reported quarterly sales of $65.15 million which beat the analyst consensus estimate of $62.60 million by 4.08 percent. This is a 4.16 percent increase over sales of $62.55 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

AAOI

Applied Optoelectronics Q3 2024 Adj EPS $(0.21) Misses $(0.17) Estimate, Sales $65.15M Beat $62.60M Estimate

Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.16 by 37.5 percent. The company reported quarterly sales of $159.300 million which beat the analyst consensus estimate of $157.566 million by 1.10 percent. This is a 11.69 percent increase over sales of $142.625 million the same period last year.

JAMF

Jamf Holding Q3 2024 Adj. EPS $0.10 Misses $0.16 Estimate, Sales $159.300M Beat $157.566M Estimate

Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.30) by 6.67 percent. The company reported quarterly sales of $58.555 million which beat the analyst consensus estimate of $53.808 million by 8.82 percent. This is a 12.39K percent increase over sales of $469.000 thousand the same period last year.

IOVA

Iovance Biotherapeutics Q3 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $58.555M Beat $53.808M Estimate

Cambium Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.17) by 17.65 percent. This is a 68.18 percent increase over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $43.73 million which missed the analyst consensus estimate of $45.31 million by 3.50 percent. This is a 1.58 percent increase over sales of $43.05 million the same period last year.

CMBM

Cambium Networks Q3 Adj $(0.14) Beats $(0.17) Estimate, Sales $43.73M Miss $45.31M Estimate

LifeMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFMD#NASDAQ">LFMD</a>) sees Q4 sales of $57.000 million-58.000 million vs $57.34 million estimate.

Guidance

LFMD

LifeMD Sees Q4 Sales $57.000M-58.000M vs $57.34M Est

Savers Value Vllage Narrows FY24 Adj. Net Income From $82M-$96M To $81M-$86M

Contracts

Bloom Energy And Quanta Computer Announced A Major Expansion Of An Existing Agreement To Power The Production Of Critical Hardware  Serving The AI Industry; Terms Not Disclosed

Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.37) by 16.22 percent. The company reported quarterly sales of $446.52 million which beat the analyst consensus estimate of $430.37 million by 3.75 percent. This is a 17.95 percent decrease over sales of $544.21 million the same period last year.

Unity Software Q3 2024 GAAP EPS $(0.31) Beats $(0.37) Estimate, Sales $446.52M Beat $430.37M Estimate

Mind Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNMD#NASDAQ">MNMD</a>) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.28) by 3.57 percent.

MNMD

Mind Medicine Q3 2024 GAAP EPS $(0.27) Beats $(0.28) Estimate

Nu Skin Sees Q4 Adj. EPS $0.19-$0.29 vs $0.28 Est., Revenue $410M-$445M vs $455.83M Est.; Sees 2024 Adj. EPS $0.65-$0.75 vs $0.77 Est., Revenue $1.7B-$1.73B vs $1.75B Est.

Air Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AL#NYSE">AL</a>) reported quarterly earnings of $1.25 per share which beat the analyst consensus estimate of $0.79 by 58.23 percent. The company reported quarterly sales of $690.16 million which beat the analyst consensus estimate of $676.82 million by 1.97 percent. This is a 4.67 percent increase over sales of $659.36 million the same period last year.

Air Lease Q3 2024 Adj EPS $1.25 Beats $0.79 Estimate, Sales $690.16M Beat $676.82M Estimate

MP Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7.69 percent. The company reported quarterly sales of $62.93 million which beat the analyst consensus estimate of $40.14 million by 56.78 percent. This is a 19.82 percent increase over sales of $52.52 million the same period last year.

MP Materials Q3 2024 Adj EPS $(0.12) Beats $(0.13) Estimate, Sales $62.93M Beat $40.14M Estimate

QuidelOrtho (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QDEL#NASDAQ">QDEL</a>) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.32 by 165.63 percent. The company reported quarterly sales of $727.10 million which beat the analyst consensus estimate of $642.10 million by 13.24 percent. This is a 2.27 percent decrease over sales of $744.00 million the same period last year.

QDEL

QuidelOrtho Q3 2024 Adj EPS $0.85 Beats $0.32 Estimate, Sales $727.10M Beat $642.10M Estimate

Yelp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YELP#NYSE">YELP</a>) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.42 by 33.33 percent. The company reported quarterly sales of $360.00 million which missed the analyst consensus estimate of $360.39 million by 0.11 percent. This is a 4.31 percent increase over sales of $345.12 million the same period last year.

YELP

Yelp Q3 2024 Adj EPS $0.56 Beats $0.42 Estimate, Sales $360.00M Miss $360.39M Estimate

FLYW

Flywire Corp Sees FY24 Ad. EBITDA $76-$80M; Q4 Adj. EBITDA $15M-$19M.

Arcturus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCT#NASDAQ">ARCT</a>) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(1.19) by 78.15 percent. The company reported quarterly sales of $41.673 million which beat the analyst consensus estimate of $36.597 million by 13.87 percent. This is a 7.68 percent decrease over sales of $45.140 million the same period last year.

ARCT

Arcturus Therapeutics Q3 2024 GAAP EPS $(0.26) Beats $(1.19) Estimate, Sales $41.673M Beat $36.597M Estimate

RDFN

Redfin Sees Q4 Revenue $237M-$247M V

Sezzle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) reported quarterly earnings of $2.62 per share. This is a 1039.13 percent increase over earnings of $0.23 per share from the same period last year. The company reported $69.96 million in sales this quarter. This is a 71.28 percent increase over sales of $40.84 million the same period last year.

SEZL

Sezzle Q3 EPS $2.62 Up From $0.23 YoY, Sales $69.96M Up From $40.84M YoY

Westrock Coffee (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEST#NASDAQ">WEST</a>) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. The company reported quarterly sales of $220.90 million which missed the analyst consensus estimate of $238.37 million by 7.33 percent. This is a 0.59 percent increase over sales of $219.61 million the same period last year.

WEST

Westrock Coffee Q3 2024 Adj EPS $(0.05) Beats $(0.06) Estimate, Sales $220.90M Miss $238.37M Estimate

Flywire Corp Sees FY24 Revenue $495M-$503M Vs $486.071M Est; Sees Q4 Revenue $121M-$129M.

Earlier this year, healthcare payments technology provider, Waystar went public to a tepid debut. The market seems to have improved now and the stock has been climbing since.

IPOs 2024: Waystar Delivers A Successful IPO

Bank of America Securities analyst Allen Lutz reiterated a Buy rating on Waystar Holding Corp. (WAY – Research Report) today and set a price target...

Waystar Holding Corp Poised for Growth Amidst RCM Vendor Shifts Post-Cyberattack

Global IPO Activity Picking Up But Continues To Lag Other Post-COVID Years

In a report released today, Stephanie Davis from Barclays maintained a Buy rating on Waystar Holding Corp. (WAY – Research Report), with a price ta...

Barclays Remains a Buy on Waystar Holding Corp. (WAY)

Sees FY24 revenue $926M-$934M, consensus $912.19M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...

Waystar sees FY24 adjusted EPS 30c-32c, consensus 27c

Waystar Holding Corp. ( ($WAY) ) has released its Q3 earnings. Here is a breakdown of the information Waystar Holding Corp. presented to its invest...

Waystar Holding Corp. Reports Strong Q3 2024 Performance

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Waystar Holding Corp. (WAY – Research Report) today and set a price target o...

Waystar Holding Corp. (WAY) Receives a Buy from Evercore ISI

Canaccord raised the firm's price target on Waystar (WAY) to $36 from $30 and keeps a Buy rating on the shares. The firm said following a strong 3Q...

Waystar price target raised to $36 from $30 at Canaccord

RBC Capital raised the firm's price target on Waystar (WAY) to $34 from $31 and keeps an Outperform rating on the shares. The company's Q3 revenue ...

Waystar price target raised to $34 from $31 at RBC Capital

Waystar Non-GAAP EPS of $0.14 misses by $0.01, revenue of $240.1M beats by $10.36M

ALAB

BTSG

IBTA

LINE

RBRK

RDDT

Fintech

Press Releases

Waystar announces term loan repricing and credit rating upgrades from Fitch, Moody's, and S&P Global

Waystar awarded top-ranking healthcare payment software platform from Black Book

Waystar to Announce Second Quarter 2024 Financial Results on August 7, 2024

Waystar Reports Second Quarter 2024 Results

Waystar CEO to Speak at Canaccord Genuity Growth Conference

Waystar Wins Stevie® Awards for Company of the Year and AI Solutions in Healthcare

New Research from Waystar and Modern Healthcare Reveals AI's Transformative Impact on Healthcare Payments

Legal

Kaskela Law LLC Announces Shareholder Investigation of Waystar Holding Corp. (NASDAQ: WAY) and Encourages Investors to Contact the Firm

Waystar to Announce Third Quarter 2024 Financial Results on November 6, 2024

Waystar Reports Third Quarter 2024 Results

Firefly Neuroscience, Inc. - Common Stock

Firefly Neuroscience

American Well Corporation Class A Common Stock

American Well

Bullfrog AI Holdings, Inc. - Common Stock

Bullfrog AI Hldgs

CareCloud

Certara

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare

Doximity

DarioHealth

Evolent Health

Forian

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings

Health Catalyst

HealthStream

icad

LifeMD

MultiPlan Corporation Class A Common Stock

MultiPlan

OptimizeRx

Phreesia

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings

Schrodinger

Simulations Plus

Sophia Genetics

TruBridge

Teladoc Health

Veeva Systems

Canaccord Genuity

RBC Capital

Goldman Sachs

Evercore ISI Group

B of A Securities

WIIM

Waystar Holding shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 guidance above estimates.

Comments

Waystar Holding

Vendite allo scoperto

Waystar Holding (NASDAQ:WAY) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO